Sandra McRee - Careview Comm Chief Officer
CRVW Stock | USD 0.03 0 12.67% |
Executive
Ms. Sandra K. McRee is the Chief Operating Officer of CareView Communications, Inc. effective November 1, 2013. Ms. McRee also currently serves as President of McRee Consulting. Ms. McRee most recently served as the Vice Chair of the Board of Directors of IASIS Healthcare Corporation from April 2010 until October 2011. Previously, she served as Chief Operating Officer of IASIS from May 2001 until October 2010, and President from May 2004 to April 2010. At IASIS, she was responsible for overseeing all aspects of IASISs hospital operations and was responsible for overseeing clinical systems developing an appropriate mix of quality services, physician relationships, effective staffing and supply utilization and managing capital investments related to operations. From April 1999 through May 2001, Ms. McRee was Regional Vice President for Province Healthcare Corporation where she oversaw five facilities in Florida, Louisiana and Mississippi. Ms. McRee has more than 35 years of healthcare management experience. Ms. McRee has spent her entire professional career in the healthcare industry. She currently serves on the Board of Directors of Denver School of Nursing. Ms. McRee previously served on the Boards of EDCare, a national emergency room management company owned by Gemini Investors from August 2005 to July 2008, MidWestern University from July 2000 to August 2004 and All About Women. Ms. McRee is a member of Women Business Leaders of the U.S. HealthCare Industry Foundation, a nonprofit organization that was established in 2001 to address the unique needs of women serving in a senior executive capacity in the U.S. healthcare industry and was a member of the Executive Leadership Team of Go Red for Women. since 2013.
Age | 67 |
Tenure | 11 years |
Phone | 972 943 6050 |
Web | https://www.care-view.com |
Careview Comm Management Efficiency
The company has return on total asset (ROA) of (0.2593) % which means that it has lost $0.2593 on every $100 spent on assets. This is way below average. Careview Comm's management efficiency ratios could be used to measure how well Careview Comm manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Susan Fischer | Aerovate Therapeutics | N/A | |
Anne DVM | Molecular Partners AG | N/A | |
Xiaohong She | Adagene | 57 | |
Sanjeev Khindri | Aerovate Therapeutics | N/A | |
Stephen Yu | Aerovate Therapeutics | N/A | |
Mary JD | PepGen | 56 | |
Ling Zhou | Adagene | N/A | |
MD MBA | Molecular Partners AG | N/A | |
Tim Smith | Pmv Pharmaceuticals | N/A | |
Daniel Steiner | Molecular Partners AG | N/A | |
Afsaneh Mohebbi | PepGen | N/A | |
Crystal Zuckerman | Pmv Pharmaceuticals | N/A | |
Renate Gloggner | Molecular Partners AG | 54 | |
Robert Ticktin | Pmv Pharmaceuticals | 62 | |
Pamela Trail | Molecular Partners AG | 68 | |
Jaya Goyal | PepGen | 56 | |
Marinus Verwijs | Aerovate Therapeutics | 48 | |
Lee Flowers | HCW Biologics | 78 | |
Erin OBoyle | Rezolute | N/A | |
Ami Knoefler | Adagene | N/A | |
Robert Hendriks | Molecular Partners AG | N/A |
Management Performance
Return On Asset | -0.26 |
Careview Comm Leadership Team
Elected by the shareholders, the Careview Comm's board of directors comprises two types of representatives: Careview Comm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Careview. The board's role is to monitor Careview Comm's management team and ensure that shareholders' interests are well served. Careview Comm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Careview Comm's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Johnson, CEO and President Treasurer, Secretary and Director | ||
Jason Thompson, Chief Officer | ||
Kyle Johnson, Director Engineering | ||
Brennan Howes, VP Devel | ||
Sandra McRee, Chief Officer | ||
Matthew Jackson, G Counsel |
Careview Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Careview Comm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.26 | |||
Profit Margin | (1.17) % | |||
Operating Margin | (0.26) % | |||
Current Valuation | 117.75 M | |||
Shares Outstanding | 142.85 M | |||
Shares Owned By Insiders | 34.63 % | |||
Price To Earning | (0.29) X | |||
Price To Sales | 1.37 X | |||
Revenue | 7.8 M | |||
Gross Profit | 5.02 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Careview OTC Stock Analysis
When running Careview Comm's price analysis, check to measure Careview Comm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Careview Comm is operating at the current time. Most of Careview Comm's value examination focuses on studying past and present price action to predict the probability of Careview Comm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Careview Comm's price. Additionally, you may evaluate how the addition of Careview Comm to your portfolios can decrease your overall portfolio volatility.